One in Every Two IBD Patients Is Zinc Deficient

By Janet Gulland, Contributing Writer

Graphic representation of the relationship between zinc deficiency, Crohn’s Disease and Ulcerative Colitis (from Zupo R, et al. Nutrients. 2022)

One in every two people with irritable bowel disease (IBD) is zinc-deficient, according to a recent systematic review of nine studies representing more than 2,400 IBD patients.

The prevalence of zinc deficiency, based on serum zinc measurements, was higher among those with Crohn’s disease (CD), affecting 54% of the patients in this subgroup, versus 41% of those with ulcerative colitis (UC).

“This is the first meta-analytic study to be conducted on the prevalence of zinc deficiency in IBD,” wrote lead author Roberta Zupo, at the Saverio de Bellis National Institute of Gastroenterology, Castellana Grotte, Italy. “The present research highlights the importance of considering zinc as a micronutrient to be monitored, because every second IBD patient shows a deficiency.”

[ ...Read More ]

Featured Articles

BAPP Program Moves Ahead to Reduce Herb Adulteration

Written by Erik Goldman

With the release of its long-awaited Standard Operating Procedure for Disposal/Destruction of Irreparably Defective Articles in November, the Botanical Adulterants Prevention Program (BAPP) has taken a major step forward in its ongoing effort to rid the nutrition and herbal medicine industries of adulterated or otherwise fraudulent ingredients. The “BAPP SOP” guidelines, as the new document […]

[ ...Read More ]

Botanical Medicine Research Roundup

Written by Janet Gulland, Contributing Writer

Research on medicinal herbs and phytochemicals continues to surge worldwide. Here are summaries of a few of the recent studies that grabbed our attention here at Holistic Primary Care. Horsetail Extract Matches Thiazide for BP Regulation A standardized extract of Horsetail (Equisetum arvense) produced clinically and statistically significant reductions in both systolic and diastolic blood […]

[ ...Read More ]

HPC Video

Hormone Replacement Therapy & Bone Health: Cyplexinol Nutritional Support

Written by Erik Goldman

Hormone Replacement Therapy & Bone Health: Cyplexinol Nutritional Support

On average bone density decreases by 10% in women during the five years of menopause due to changes in estrogen. While Hormone Replacement Therapy offers support in maintaining bone health, there can be a precipitous loss when women discontinue HRT.

Along with the decline in estrogen, there is a concurrent 40% drop in production of bone-stimulating Growth Factor Proteins in the menopausal period, which can lead to dysregulation of bone remodeling.

While HRT is well-established for estrogen support, there’s a largely unmet need to address this decline of Growth Factor Proteins.

In this free webinar, women’s health expert Jaquel Patterson, ND, will explore how a nutraceutical called Cyplexinol®–a growth factor complex patented for osteoinductive properties–can be used support HRT protocols for improved bone density outcomes.

Discover how the age-related decreases in estrogen and Growth Factor Proteins affect women’s bone health, and the nutritional interventions you can provide to support healthy bone remodeling.


Jaquel Patterson, ND, MBA is the founder and medical director of Fairfield Family Health, an integrative medicine clinic in Fairfield, CT. Dr. Patterson is a nationally-recognized naturopathic physician, specializing in Lyme disease, autoimmune conditions, anxiety/depression, childhood developmental disorders, and women’s health. She received her ND degree from the University of Bridgeport College of Naturopathic Medicine, and earned an MBA in healthcare administration from Quinnipiac University. She is a past-president of the American Association of Naturopathic Physicians, and a popular author and speaker for many health and fitness media outlets.

[ ...Read More ]